Portuguese Inguinal Hernia Cohort (PINE) Study (PINE)

Portuguese Inguinal Hernia Cohort Study

Prospective national cohort study of patients submitted to elective inguinal hernia repair. The primary outcome is the prevalence of chronic postoperative inguinal pain, according to the EuraHS QoL questionnaire at 3 months postoperatively. The study will be delivered in all Portuguese regions through a collaborative research network. Four 2-week inclusion periods will be open for recruitment. A site-specific questionnaire will capture procedure volume and logistical facilities for hernia surgery.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lisboa, Portugal
        • Hospital Prof. Dr. Fernando Fonseca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Portuguese patients undergoing inguinal hernia repair in one of the hospitals participating in the study

Description

Inclusion Criteria:

  • Elective inguinal hernia repair in a portuguese hospital
  • Willing and able to consent and comply with the follow up protocol

Exclusion Criteria:

  • Urgent/emergent inguinal hernia repair

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic postoperative pain
Patients scoring 3 or more on the EuraHS Quality of Life assessment after elective inguinal hernia repair
Inguinal hernia repair (open, laparo-endoscopic, robotic)
Other Names:
  • surgery
Non chronic postoperative pain
Patients scoring less than 3 on the EuraHS Quality of Life assessment after elective inguinal hernia repair
Inguinal hernia repair (open, laparo-endoscopic, robotic)
Other Names:
  • surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic postoperative pain
Time Frame: 3 months postoperatively
Score of 3 or above on the pain domains of the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS QoL) assessment, with higher scores indicating higher pain
3 months postoperatively

Secondary Outcome Measures

Outcome Measure
Time Frame
Postoperative morbidity
Time Frame: 30 days after surgery
30 days after surgery
Proportion of patients receiving antibiotic prophylaxis before inguinal hernia repair
Time Frame: Intraoperatively
Intraoperatively
Proportion of patients operated as day case surgery
Time Frame: 30 days after surgery
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Antonio Soares, Portuguese Surgical Research Collaborative

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2019

Primary Completion (Anticipated)

June 12, 2020

Study Completion (Anticipated)

August 12, 2020

Study Registration Dates

First Submitted

March 25, 2020

First Submitted That Met QC Criteria

March 30, 2020

First Posted (Actual)

March 31, 2020

Study Record Updates

Last Update Posted (Actual)

April 1, 2020

Last Update Submitted That Met QC Criteria

March 30, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plans are made to share patient data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe